Comparative activity of N-(4-hydroxyphenyl)-all-trans-retinamide and α-difluoromethylornithine as inhibitors of lymphoma induction in PIM transgenic mice

Carcinogenesis

Volumn 17, Issue 11, 1996, Pages 2513-2517

  McCormick, David L ^a   Johnson, William D ^a   Rao, K V N ^a   Bowman Gram, Teresa ^a   Steele, Vernon E ^b   Lubet, Ronald A ^b   Kelloff, Gary J ^b  

^a IIT RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EFLORNITHINE; ETHYLNITROSOUREA; FENRETINIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CANCER MORTALITY; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; LYMPHOMA; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0029830207     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.11.2513     Document Type: Article

References (19)

1. Haran-Ghera, N., Peled, A., Brightman, B.K. and Fan, H. (1993) Lymphomagenesis in AKR.Fv-Ib congenic mice. Cancer Res., 53, 3433-3438.
2. Harris, G. and Lawley, P.D. (1994) The susceptibility of inbred mice to the production of malignant thymoma by N-methyl-N-nitrosourea. Carcinogenesis, 15, 1211-1219.
3. Yamada, Y., Matsushiro, H., Ogawa, M.S., Okamoto, K., Nakakuki, Y. Toyokuni, S., Fukumoto, M. and Hiai, H. (1994) Genetic predisposition to pre-B lymphomas in SL/Kh strain mice. Cancer Res., 54, 403-407.
4. Breuer, M., Slebos, R., Verbeek, S., von Lohuizen, M., Wientjens, E. and Berns, A. (1989) Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature, 340, 61-63.
5. Breuer, M., Wientjens, E., Verbeek, S., Slebos, R. and Berns, A. (1991) Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. Cancer Res., 51, 958-963.
6. van Lohuizen, M., Verbeek, K., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T., and Berns, A. (1989) Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell, 56, 673-682.
7. Costa, A., Formelli, F., Chiesa, F., Decensi, A., DePalo, G. and Veronesi, U. (1994) Prospects of chemoprevention of human cancers with synthetic retinoid fenretinide. Cancer Res., 54, 2032s-2037s.
8. Creaven, P.J., Pendyala, L. and Porter, C.W. (1993) Evaluation of α-difluoromethyl-ornithine as a potential chemopreventive agent: tolerance to daily oral administration in humans. Cancer Epidemiol. Biomarkers Prev., 2, 235-241.
9. Kelloff, G.J., Boone, C.W., Steele, V.E., Crowell, J.A., Lubet, R. and Sigman, C.C. (1994) Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res., 54, 2015s-2024s.
10. Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J. and Smith, P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35, 1-39.
11. Moon, R.C., Thompson, H.J., Becci, P.J. et al. (1979) N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res., 39, 1339-1346.
12. McCormick, D.L., Mehta, R.G., Thompson, C.A., Dinger, N., Caldwell, J.A. and Moon, R.C. (1982) Enhanced inhibition of mammary carcinogenesis by combination N-(4-hydroxyphenyl)retinamide and ovariectomy. Cancer Res., 42, 508-512.
13. Moon, R.C., McCormick, D.L., Becci, P.J., Shealy, Y.F., Frickel, F., Paust, J. and Sporn, M.B. (1982) Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouse. Carcinogenesis, 3, 1469-1472.
14. McCormick, D.L., Becci, P.J. and Moon, R.C. (1982) Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydridedivinyl ether copolymer (MVE-2). Carcinogenesis, 3, 1473-1477.
15. McCormick, D.L. and Moon, R.C. (1986) Antipromotional activity of dietary N-(4-hydroxyphenyl)retinamide in two-stage tumorigenesis in CD-1 and SENCAR mice. Cancer Lett., 31, 133-138.
16. McCormick, D.L., Burns, F.J. and Albert, R.E. (1980) Inhibition of rat mammary carcinogenesis by short dietary exposure to retinyl acetate. Cancer Res., 40, 1140-1143.
17. Thompson, H.J., Becci, P.J., Brown, C.C. and Moon, R.C. (1979) Effect of the duration of retinyl acetate feeding on inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat. Cancer Res., 39, 3977-3980.
18. Warrell, R.P. Jr, Frankel, S.R., Miller, W.H. Jr et al. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med., 324, 1385-1393.
19. Smith, M.A., Parkinson, D.R., Cheson, B.D. and Friedman, M.A. (1992) Retinoids in cancer therapy. J. Clin. Oncol., 10, 839-864.